The functions and regulation of the PTEN tumour suppressor
The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Abstract
The importance of the physiological function of phosphatase and tensin homologue (PTEN) is illustrated by its frequent disruption in cancer. By suppressing the phosphoinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway through its lipid phosphatase activity, PTEN governs a plethora of cellular processes including survival, proliferation, energy metabolism and cellular architecture. Consequently, mechanisms regulating PTEN expression and function, including transcriptional regulation, post-transcriptional regulation by non-coding RNAs, post-translational modifications and protein-protein interactions, are all altered in cancer. The repertoire of PTEN functions has recently been expanded to include phosphatase-independent activities and crucial functions within the nucleus. Our increasing knowledge of PTEN and pathologies in which its function is altered will undoubtedly inform the rational design of novel therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the majority of prostate cancer patients at presentation have lost one allele of PTEN while maintaining intact TP53; whereas TP53 mutations and the complete loss of PTEN are both associated with advanced stage prostate cancer 153,154”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [154]
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Self-citationAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Cited by
Items 601–700 of 1,010
Mirantes, C., Eritja, N., Dosil, M. A., Santacana, M., Pallarés, J., Gatius, S., Bergadà, L., Maiques, Ó., Matías‐Guiu, X., & Dolcet, X. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.011445 · Cited by 56
Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women
Motawi, T. K., Sadik, N. A. H., Shaker, O. G., Masry, M. R. E., & Mohareb, F. R. (2016) · Gene · doi:10.1016/j.gene.2016.01.042 · Cited by 46
Xiong, C., Masucci, M. V., Zhou, X., Liu, N., Zang, X., Tolbert, E. M., Zhao, T. C., & Zhuang, S. (2016) · Oncotarget · doi:10.18632/oncotarget.12498 · Cited by 46
Niu, Y., Sun, W. C., Lu, J., Ma, D., Leung, C., Pei, L., & Chen, X. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/4313204 · Cited by 45
The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein
Chen, M., Nowak, D. G., Narula, N., Robinson, B. D., Watrud, K. E., Ambrico, A. J., Herzka, T. M., Zeeman, M. E., Minderer, M., Zheng, W., et al. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201604025 · Cited by 45
Zhan, M., Deng, Y., Zhao, L., Yan, G., Wang, F., Tian, Y., Zhang, L., Jiang, H., & Chen, Y. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00357 · Cited by 45
Li, W., Li, W., Laishram, R. S., Hoque, M., Ji, Z., Tian, B., & Anderson, R. A. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx560 · Cited by 45
SIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancer
Xiong, Y., Wang, L., Wang, S., Wang, M., Zhao, J., Zhang, Z., Li, X., Jia, L., & Han, Y. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2537-9 · Cited by 44
Intracellular lipid metabolism impairs β cell compensation during diet-induced obesity
Ye, R., Gordillo, R., Shao, M., Onodera, T., Chen, Z., Chen, S., Lin, X., SoRelle, J. A., Li, X., Tang, M., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97702 · Cited by 51
Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett’s Esophagus
Li, X., Kleeman, S. O., Coburn, S. B., Fumagalli, C., Perner, J., Jammula, S., Pfeiffer, R. M., Orzolek, L. D., Hao, H., Taylor, P. R., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.050 · Cited by 46
FBXO17 promotes cell proliferation through activation of Akt in lung adenocarcinoma cells
Suber, T. L., Nikolli, I., O’Brien, M. E., Londino, J. D., Zhao, J., Chen, K., Mallampalli, R. K., & Zhao, Y. (2018) · Respiratory Research · doi:10.1186/s12931-018-0910-0 · Cited by 50
Cao, P., Nie, G., Luo, J., Hu, R., Li, G., Hu, G., & Zhang, C. (2022) · Food & Function · doi:10.1039/d1fo02855c · Cited by 44
Caviglia, J. M., & Schwabe, R. F. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2297-0_8 · Cited by 46
PTEN suppresses tumorigenesis by directly dephosphorylating Akt
Bu, L., Wang, H., Pan, J., Chen, L., Xing, F., Wu, J., Li, S., & Guo, D. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00571-x · Cited by 46
Prostate cancer progression and metastasis: potential regulatory pathways for therapeutic targeting.
Nandana, S., & Chung, L. W. K. (2014) · PubMed · Cited by 44
miR-144/451 Promote Cell Proliferation via Targeting PTEN/AKT Pathway in Insulinomas
Jiang, X., Shan, A., Su, Y., Cheng, Y., Gu, W., Wang, W., Ning, G., & Cao, Y. (2015) · Endocrinology · doi:10.1210/en.2014-1966 · Cited by 43
Morrow, A. A., Alipour, M. A., Bridges, D., Yao, Z., Saltiel, A. R., & Lee, J. M. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0604 · Cited by 48
Choorapoikayil, S., Kers, R., Herbomel, P., Kissa, K., & den Hertog, J. (2013) · Blood · doi:10.1182/blood-2013-05-501544 · Cited by 45
Cheng, Y., Tian, Y., Xia, J., Wu, X., Yang, Y., Li, X., Huang, C., Meng, X., Ma, T., & Li, J. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.01.005 · Cited by 42
Activating Akt1 mutations alter DNA double strand break repair and radiosensitivity
Oeck, S., Al-Refae, K., Riffkin, H., Wiel, G., Handrick, R., Klein, D., Iliakis, G. E., & Jendrossek, V. (2017) · Scientific Reports · doi:10.1038/srep42700 · Cited by 44
miR-214 promotes radioresistance in human ovarian cancer cells by targeting PETN
Zhang, Q., & Zhang, S. (2017) · Bioscience Reports · doi:10.1042/bsr20170327 · Cited by 43
Nie, Z.-Y., Yang, L., Liu, X., Yang, Z., Yang, G., Zhou, J., Qin, Y., Yu, J., Jiang, L., Wen, J., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0051 · Cited by 43
MicroRNAs Modulate Drug Resistance-Related Mechanisms in Hepatocellular Carcinoma
Liang, Y., Liang, Q., Qiao, L., & Xiao, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00920 · Cited by 45
PTENα functions as an immune suppressor and promotes immune resistance in PTEN-mutant cancer
Sun, Y., Lü, D., Yin, Y., Song, J., Liu, Y., Hao, W., Qi, F., Zhang, X., Zhang, X., Lin, Z., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25417-6 · Cited by 43
Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment Paradigms
Chang, C., Chavarro, V. S., Gerstl, J. V. E., Blitz, S. E., Spanehl, L., Dubinski, D., Valdes, P. A., Tran, L. N., Gupta, S., Esposito, L., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126733 · Cited by 45
Kar, S., Samii, A., & Bertalanffy, H. (2014) · Neurosurgical Review · doi:10.1007/s10143-014-0597-8 · Cited by 44
Noncoding RNAs in Regulation of Cancer Metabolic Reprogramming
Yang, D., Sun, L., Li, Z., & Gao, P. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-1498-7_7 · Cited by 43
Structural basis for interdomain communication in SHIP2 providing high phosphatase activity
Le Coq, J., Camacho-Artacho, M., Velázquez, J. V., Santiveri, C. M., Gallego, L. H., Campos-Olivas, R., Dölker, N., & Lietha, D. (2017) · eLife · doi:10.7554/elife.26640 · Cited by 42
Coordination of Necessary and Permissive Signals by PTEN Inhibition for CNS Axon Regeneration
Zhang, J., Yang, D., Huang, H., Sun, Y., & Hu, Y. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00558 · Cited by 43
PTEN Hamartoma Tumor Syndrome and Immune Dysregulation
Eissing, M., Ripken, L., Schreibelt, G., Westdorp, H., Ligtenberg, M. J. L., Netea-Maier, R. T., Netea, M. G., de Vries, I. J. M., & Hoogerbrugge, N. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.11.003 · Cited by 46
C-Jun drives melanoma progression in PTEN wild type melanoma cells
Kappelmann‐Fenzl, M., Gebhard, C., Matthies, A. O., Kuphal, S., Rehli, M., & Bosserhoff, A. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1821-9 · Cited by 49
Multifaceted Regulation of PTEN Subcellular Distributions and Biological Functions
Liu, T., Wang, Y., Wang, Y., & Chan, A. M.-L. (2019) · Cancers · doi:10.3390/cancers11091247 · Cited by 43
Chen, Y., Yu, H., Zhu, D., Liu, P., Yin, J., Liu, D., Zheng, M., Gao, J., Zhang, C., & Gao, Y. (2020) · The FASEB Journal · doi:10.1096/fj.201902463rr · Cited by 43
The role of deubiquitinases in breast cancer
Xiao, Z., Zhang, P., & Ma, L. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9640-2 · Cited by 43
Li, Z., Liu, Y., Tian, Y., Li, Q., Shi, W., Zhang, J., Zhang, H., Tan, Y. C., Yang, S., Yang, T., et al. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5297 · Cited by 47
Kalli, A. C., Devaney, I., & Sansom, M. S. P. (2014) · Biochemistry · doi:10.1021/bi5000299 · Cited by 42
miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway
Xiao, J., Yu, W., Hu, K., Li, M., Chen, J., & Li, Z. (2017) · Oncology Reports · doi:10.3892/or.2017.5484 · Cited by 41
Oh, S., Kim, H., Nam, K., & Shin, I. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.08.009 · Cited by 43
Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid Liposarcoma
Trautmann, M., Cyra, M., Isfort, I., Jeiler, B., Krüger, A., Grünewald, I., Steinestel, K., Altvater, B., Rossig, C., Hafner, S., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0763 · Cited by 40
PTEN improve renal fibrosis in vitro and in vivo through inhibiting FAK/AKT signaling pathway
Du, Y., Liu, P., Chen, Z., He, Y., Zhang, B., Dai, G., Xia, W., Liu, Y., & Chen, X. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29057 · Cited by 43
Morschhauser, F., Machiels, J., Salles, G. A., Rottey, S., Rule, S. A., Cunningham, D., Peyrade, F., Fruchart, C., Arkenau, H., Genvresse, I., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0466 · Cited by 42
Zhang, H., Wang, Z., Dai, Z., Wu, W., Cao, H., Li, S., Zhang, N., & Cheng, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.694490 · Cited by 52
Secreted PTEN binds PLXDC2 on macrophages to drive antitumor immunity and tumor suppression
Zhang, C., Ma, H., Wu, S., Shen, J., Zhang, N., Xu, Y., Li, C.-X., He, P., Ge, M.-K., Chu, X., et al. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.08.003 · Cited by 42
The injured axon: intrinsic mechanisms driving axonal regeneration
Tomé, D., & Almeida, R. D. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.09.009 · Cited by 40
Arthur, L. M., Turnbull, A., Renshaw, L., Keys, J., Thomas, J., Wilson, T. R., Lackner, M. R., Sims, A. H., & Dixon, J. M. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3080-x · Cited by 42
WANG, D., Wang, S., Liu, Q., WANG, M., Wang, C., & Yang, H. (2013) · Oncology Reports · doi:10.3892/or.2013.2376 · Cited by 40
Kreis, P., Hendricusdottir, R., Kay, L., Papageorgiou, I. E., van Diepen, M. T., Mack, T. G. A., Ryves, J., Harwood, A. J., Leslie, N. R., Kann, O., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071957 · Cited by 49
CRISPR-Cas9: from Genome Editing to Cancer Research
Chen, S., Sun, H., Miao, K., & Deng, C. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.17421 · Cited by 47
Spatial Activation of TORC1 Is Regulated by Hedgehog and E2F1 Signaling in the Drosophila Eye
Kim, W., Jang, Y., Yang, J., & Chung, J. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.07.020 · Cited by 38
Carli, J. F. M., LeDuc, C. A., Zhang, Y., Stratigopoulos, G., & Leibel, R. L. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m085555 · Cited by 44
β-Arrestins: Multitask Scaffolds Orchestrating the Where and When in Cell Signalling
Laporte, S. A., & Scott, M. G. H. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9158-7_2 · Cited by 45
Korshunova, I., Rhein, S., García‐González, D., Stölting, I., Pfisterer, U., Barta, A., Dmytriyeva, O., Kirkeby, A., Schwaninger, M., & Khodosevich, K. (2020) · JCI Insight · doi:10.1172/jci.insight.126268 · Cited by 41
Li, C., Xu, X., Wang, Z., Wang, Y., Luo, L., Cheng, J., Chen, S., Liu, H.-J., Wan, Q., & Wang, Q. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146777 · Cited by 42
Lai, X., Wei, J., Gu, X.-Z., Yao, X.-M., Zhang, D.-S., Li, F., & Sun, Y.-Y. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16478 · Cited by 37
Liu, Y., Qiu, G., Luo, Y., Li, S., Xu, Y., Zhang, Y., Hu, J., Li, P., Pan, H., & Wang, Y. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00806-z · Cited by 41
Al‐Ansari, M. M., & Aboussekhra, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090907 · Cited by 49
Liu, Z., Jiang, J., Yang, Q., Xiong, Y., Zou, D., Yang, C., Xu, J., & Zhan, H. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.84 · Cited by 40
The Double-Edged Sword of SIRT3 in Cancer and Its Therapeutic Applications
Ouyang, S., Zhang, Q., Lou, L., Zhu, K., Li, Z., Liu, P., & Zhang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.871560 · Cited by 47
Alelaimat, M. A., Al-Sha’er, M. A., & Basheer, H. A. (2023) · ACS Omega · doi:10.1021/acsomega.3c01273 · Cited by 39
Receptor Trafficking and the Regulation of Synaptic Plasticity by SUMO
Luo, J., Ashikaga, E., Rubin, P. P., Heimann, M. J., Hildick, K. L., Bishop, P., Girach, F., Josa‐Prado, F., Tang, L. T. H., Carmichael, R. E., et al. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8253-y · Cited by 44
Huang, S., Sung, C., Chen, W.-F., Chen, C., Feng, C., Yang, S., Hung, H.-C., Chen, N., Lin, P.-R., Chen, S., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0280-1 · Cited by 42
Maiques, Ó., Santacana, M., Valls, J., Pallarés, J., Mirantes, C., Gatius, S., Garcia-Dios, D. A., Amant, F. C., Pedersen, H. C., Dolcet, X., et al. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.10.018 · Cited by 46
Cholewa, B. D., Pellitteri-Hahn, M. C., Scarlett, C. O., & Ahmad, N. (2014) · Journal of Proteome Research · doi:10.1021/pr5002516 · Cited by 39
Battistella, M., Romero, M. L., Castro‐Vega, L. J., Gapihan, G., Bouhidel, F. A., Bagot, M., Feugeas, J., & Janin, A. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.27 · Cited by 41
Intracellular delivery of the PTEN protein using cationic lipidoids for cancer therapy
Altınoğlu, S. A., Wang, M., Li, K. Q., Li, Y., & Xu, Q. (2016) · Biomaterials Science · doi:10.1039/c6bm00580b · Cited by 39
Tang, L., Li, X., Gao, Y., Chen, L., Gu, L., Chen, J., Lyu, X., Zhang, Y., & Zhang, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179437 · Cited by 39
Liu, X., Zhang, Y., Shi, M., Wang, Y.-Y., Zhang, F., Yan, R., Liu, L., Xiao, Y., & Guo, B. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.187 · Cited by 41
Nguyen, L. H., & Anderson, A. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-21656-8 · Cited by 39
Ranganna, K., Selvam, C., Shivachar, A. C., & Yousefipour, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218198 · Cited by 41
Cizmecioglu, O., Ni, J., Xie, S., Zhao, J. J., & Roberts, T. M. (2016) · eLife · doi:10.7554/elife.17635 · Cited by 47
The equilibrium of tumor suppression: DUBs as active regulators of PTEN
Christine, A., Park, M. K., Song, S. J., & Song, M. S. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00887-w · Cited by 44
Self-citationExtrinsic and intrinsic regulation of axon regeneration at a crossroads
Kaplan, A., Tone, S. O., & Fournier, A. E. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00027 · Cited by 40
Phospholipid-binding Sites of Phosphatase and Tensin Homolog (PTEN)
Wei, Y., Stec, B., Redfield, A. G., Weerapana, E., & Roberts, M. F. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.588590 · Cited by 37
Nowak, K., Seisenbacher, G., Hafen, E., & Stocker, H. (2013) · eLife · doi:10.7554/elife.00380 · Cited by 38
Pten loss in the bone marrow leads to G-CSF–mediated HSC mobilization
Tesio, M., Oser, G. M., Baccelli, I., Blanco-Bose, W., Wu, H., Göthert, J. R., Kogan, S. C., & Trumpp, A. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122768 · Cited by 35
Picanço-Albuquerque, C. G., Morais, C. L., Carvalho, F. L. F., Peskoe, S. B., Hicks, J. L., Ludkovski, O., Vidotto, T., Fedor, H. L., Humphreys, E. B., Han, M., et al. (2016) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-016-1904-2 · Cited by 38
Interleukin-30 Promotes Breast Cancer Growth and Progression
Airoldi, I., Cocco, C., Sorrentino, C., Angelucci, D., Meo, S. D., Manzoli, L., Esposito, S., Ribatti, D., Bertolotto, M. B., Iezzi, L., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0189 · Cited by 41
A PTEN-Regulated Checkpoint Controls Surface Delivery of δ Opioid Receptors
Shiwarski, D. J., Tipton, A. F., Giraldo, M. D., Schmidt, B. F., Gold, M. S., Pradhan, A. A. A., & Puthenveedu, M. A. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2923-16.2017 · Cited by 38
Geybels, M. S., Fang, M., Wright, J. L., Qu, X., Bibikova, M. V., Klotzle, B., Fan, J., Feng, Z., Ostrander, E. A., Nelson, P. S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20940 · Cited by 43
PTEN Physically Interacts with and Regulates E2F1-mediated Transcription in Lung Cancer
Malaney, P., Palumbo, E., Semidey-Hurtado, J., Hardee, J., Stanford, K., Kathiriya, J. J., Patel, D., Tian, Z., Allen‐Gipson, D., & Davé, V. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1388970 · Cited by 42
Local Cortisol Elevation Contributes to Endometrial Insulin Resistance in Polycystic Ovary Syndrome
Qi, J., Wang, W., Zhu, Q., He, Y., Lu, Y., Wang, Y., Li, X., Chen, Z., & Sun, Y. W. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02459 · Cited by 39
SIRT4 regulates PTEN stability through IDE in response to cellular stresses
Liu, M., Wang, Z., Ren, M., Yang, X. P., Liu, B., Qi, H., Yu, M., Shi, S., Chen, S., Liu, L., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801987r · Cited by 38
Wang, Q., Feng, Y., Peng, W., Ji, D., Zhang, Z., Qian, W., Li, J., Gu, Q., Zhang, D., Tang, J., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.02.041 · Cited by 38
STAT3 dictates β-cell apoptosis by modulating PTEN in streptozocin-induced hyperglycemia
Weng, Q., Zhao, M., Zheng, J., Yang, L., Xu, Z., Zhang, Z., Wang, J., Wang, J., Yang, B., Lu, Q. R., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0344-3 · Cited by 41
The expanding spectrum of neurological disorders of phosphoinositide metabolism
Volpatti, J. R., Al-Maawali, A. A., Smith, L., Alhashim, A. H., Brill, J. A., & Dowling, J. J. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.038174 · Cited by 43
“In the PI3K/Akt pathway, the 3-phosphatase PTEN acts as a negative regulator of PI3K signaling owing to its ability to hydrolyze PtdIns(3,4,5)P 3 (Song et al., 2012).”
Alhoshani, A., Alanazi, F. E., Alotaibi, M. R., Attwa, M. W., Kadi, A. A., Al‐Dhfyan, A., Akhtar, S., Hourani, S., Agouni, A., Zeidan, A., et al. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00005 · Cited by 40
Targeting DNA to the endoplasmic reticulum efficiently enhances gene delivery and therapy
Qin, B., Yuan, X., Jiang, M., Yin, H., Luo, Z., Zhang, J., Zhu, C., Li, X., Shi, Y., Luo, L., et al. (2020) · Nanoscale · doi:10.1039/d0nr03156a · Cited by 38
RETRACTED: Angioregulatory role of miRNAs and exosomal miRNAs in glioblastoma pathogenesis
Bouzari, B., Mohammadi, S., Bokov, D. O., Krasnyuk, I. I., Hosseini‐Fard, S. R., Hajibaba, M., Mirzaei, R., & Karampoor, S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112760 · Cited by 40
RetractedA new class of cancer-associated PTEN mutations defined by membrane translocation defects
Nguyen, H.-N., Yang, J.-M., Jr., Rahdar, M., Keniry, M. E., Swaney, K. F., Parsons, R. E., Park, B. H., Sesaki, H., Devreotes, P. N., & Iijima, M. (2014) · Oncogene · doi:10.1038/onc.2014.293 · Cited by 42
Jie, C., Li, R., Cheng, Y., Wang, Z., Wu, Q., & Xie, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1122352 · Cited by 40
Bitanihirwe, B. K. Y., Meerang, M., Friess, M., Soltermann, A., Frischknecht, L., Thies, S., Felley‐Bosco, E., Tsao, M., Allo, G., de Perrot, M. E., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000055 · Cited by 39
Rafii, S., Roda, D., Geuna, E., Jiménez, B., Rihawi, K., Capelán, M., Yap, T. A., Molife, L. R., Kaye, S. B., Bono, J. S. D., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2424 · Cited by 41
Wu, Q., YUAN, S.-X., REN, C.-M., YU, Y., Sun, W., He, B., & Wu, K. (2016) · Oncology Reports · doi:10.3892/or.2016.4735 · Cited by 37
Han, R., Gao, J., Zhai, H., Xiao, J., Ding, Y., & Hao, J. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.04.005 · Cited by 37
Xiong, S., Cheng, J., Klausen, C., Zhao, J., & Leung, P. C. K. (2016) · Oncotarget · doi:10.18632/oncotarget.11311 · Cited by 37
Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer
Sax, M. J., Gasch, C., Athota, V. R., Freeman, R., Rasighaemi, P., Westcott, D. E., Day, C. J., Nikolić, I., Elsworth, B., Wei, M. Q., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13387 · Cited by 41
Ryu, J., Choe, S. S., Ryu, S.-H., Park, E., Lee, B. W., Kim, T. K., Ha, C. H., & Lee, S.-W. (2016) · Oncotarget · doi:10.18632/oncotarget.13809 · Cited by 40
Protective role of microRNA-221 in Parkinson’s disease
Li, L., Xu, J., Wu, M., & Hu, J. (2018) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2018_005 · Cited by 41
The Axonal Membrane Protein PRG2 Inhibits PTEN and Directs Growth to Branches
Brosig, A., Fuchs, J., Ipek, F., Kroon, C., Schrötter, S., Vadhvani, M., Polyzou, A., Ledderose, J., van Diepen, M., Holzhütter, H.-G., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.039 · Cited by 37
Zhu, L., Lin, X., Zhi, L., Fang, Y., Lin, K., Li, K., & Wu, L. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1543-z · Cited by 38
Metadata
- Authors
- Song, M. S., Salmena, L., & Pandolfi, P. P.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Song, Min Sup
- Salmena, Leonardo
- Pandolfi, Pier Paolo
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2012-04-04
- Volume
- 13
- Issue
- 5
- Pages
- 283-296
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2017739035
- Cited by
- 1,926
- References
- 159
- Citations by year
- 2026: 50 · 2025: 81 · 2024: 85 · 2023: 100 · 2022: 124 · 2021: 113 · 2020: 147 · 2019: 155 · 2018: 172 · 2017: 183 · 2016: 167 · 2015: 182 · 2014: 199 · 2013: 136 · 2012: 31
- FWCI
- 15.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Canadian Institutes of Health Research
- National Cancer Institute (R01 CA-82328-09, R01CA082328)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- PTEN, phosphatase and tensin homologue, tumour suppressor, PI3K/AKT/mTOR pathway, lipid phosphatase activity, transcriptional regulation, non-coding RNA, post-translational modification, protein-protein interaction, cancer therapy, energy metabolism, cell proliferation
- MeSH terms
- Animals, Cell Nucleus, Gene Expression Regulation, Humans, Mutation, Neoplasms, Protein Conformation, Neoplastic Stem Cells, Signal Transduction, Tumor Suppressor Proteins, PTEN Phosphohydrolase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.